Additional Listing – 15 March 2011
As announced on 18 February 2011, as part of the initial consideration for the acquisition of ClaimTrust, Inc. (“ClaimTrust”), the Company will apply for 641,917 New Ordinary Shares of 1p each (“New Ordinary Shares”) to be admitted to AIM, in weekly aggregate instalments, following satisfaction by each of the vendors of the necessary regulatory documentation.
In this regard, regulatory documentation satisfaction by a number of vendors has resulted in the Company applying for a further 3,640 New Ordinary Shares to be admitted to trading on AIM. These shares will rank pari passu with the existing issued ordinary shares of the Company and dealings are expected to commence on 21 March 2011. Of the total 641,917 New Ordinary Shares to be admitted to AIM in connection with the acquisition of ClaimTrust, 632,723 are subject to a twelve month lock in and 96,407 of the total are still to be applied for.
Following this admission of New Ordinary Shares, the total number of shares in issue with voting rights will be 26,510,460.
For further information, please contact:
- +44 (0) 131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
- +44 (0) 20 7418 8900
- Oliver Scott
- Nicholas Marren
- +44 (0) 20 7653 9850
- Caroline Evans-Jones
- Fiona Conroy
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware’s market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimise compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.
You might also like...
Dec 21, 2018 | Announcements
Strong performance expected to deliver revenue and adjusted EBITDA growth in the range of 15% to 20% 21 December 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, notes the recent...read more
Nov 9, 2018 | Announcements
09 November 2018 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2018. For those shareholders...read more